Internal Medicine, Pulmonary Disease · Kinston, NC
NPI
1821314014
Since 2010
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
706 Rosanne Dr
Kinston, NC, 28504
Phone (525) 527-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
1,395 services
Medicare patients, 2024
487
Average age 73
Drug cost, 2024
$2.6M
4,563 prescriptions
Company payments, 2025
$258
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luz J Barahona was code 99214 (office e&m - established), 323 times for 240 patients. In total Luz J Barahona billed 1,395 services in 40 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 323 | 240 | $87.92 | $28K |
| 99215 Office E&M - Established | Office | 230 | 160 | $129.76 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 122 | 68 | $58.59 | $7,148 |
| 99291 Critical Care E&M | Facility | 66 | 28 | $154.39 | $10K |
| 99223 Hospital E&M - Initial | Facility | 64 | 60 | $125.62 | $8,039 |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 36 | $88.06 | $4,931 |
| G0008 Administration of influenza virus vaccine | Office | 53 | 53 | $30.39 | $1,611 |
| 99407 Behavioral Health Services | Office | 51 | 39 | $25.11 | $1,281 |
| 90662 Vaccine Product | Office | 48 | 48 | $81.82 | $3,927 |
| 94060 Pulmonary Function Testing | Facility | 37 | 37 | $7.38 | $273 |
| 94726 Pulmonary Function Testing | Facility | 34 | 34 | $8.43 | $286 |
| 94729 Pulmonary Function Testing | Facility | 32 | 32 | $6.09 | $195 |
| 99213 Office E&M - Established | Office | 31 | 27 | $61.17 | $1,896 |
| 99205 Office E&M - New | Office | 25 | 25 | $147.62 | $3,691 |
| 71046 X-ray - Chest | Office | 15 | 15 | $23.03 | $345 |
By year: 2022 $158K for 1,951 services; 2023 $110K for 1,253 services; 2024 $108K for 1,395 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luz J Barahona prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 676 prescriptions and refills. In total Luz J Barahona wrote 4,563 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 676 | 768 | 146 | $486K |
| Montelukast Sodium Generic | 509 | 841 | 143 | $3,591 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 495 | 652 | 192 | $14K |
| Prednisone Generic | 298 | 321 | 151 | $799 |
| Fluticasone Propionate Generic | 180 | 280 | 76 | $1,995 |
| Breo Ellipta Fluticasone/Vilanterol | 148 | 180 | 39 | $72K |
| Symbicort Budesonide/Formoterol Fumarate | 135 | 162 | 35 | $36K |
| Nucala Mepolizumab | 128 | 133 | 14 | $609K |
| Ventolin Hfa Albuterol Sulfate | 125 | 145 | 57 | $8,255 |
| Trazodone Hcl Generic | 105 | 150 | 30 | $923 |
| Advair Hfa Fluticasone Propion/Salmeterol | 99 | 111 | 20 | $36K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 90 | 96 | 20 | $60K |
| Doxycycline Hyclate Generic | 89 | 89 | 58 | $562 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 84 | 108 | 21 | $51K |
| Furosemide Generic | 77 | 100 | 31 | $205 |
Brand drugs: 2,192 claims; generic drugs: 2,371 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luz J Barahona $258 ($258 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $120.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.